Agios Pharmaceuticals (AGIO) Is Up 5.4% After Mixed 2025 Results And AQVESME Launch Progress [Yahoo! Finance]
Agios Pharmaceuticals Inc (AGIO) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
Agios Pharmaceuticals (NASDAQ:AGIO) had its price target raised by analysts at HC Wainwright from $62.00 to $65.00. They now have a "buy" rating on the stock.
Agios Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Agios Pharmaceuticals: Q4 Earnings Snapshot [Yahoo! Finance]